Page last updated: 2024-08-24

fluorodeoxyglucose f18 and u 0126

fluorodeoxyglucose f18 has been researched along with u 0126 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alauddin, M; Bankson, J; Flores, LG; Gelovani, JG; Hu, Q; Huff, V; Soghomonyan, S; Yeh, HH; Young, D	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and u 0126

Article	Year
Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth. Molecular imaging and biology, 2013, Volume: 15, Issue:2 Topics: Animals; Butadienes; Female; Fluorodeoxyglucose F18; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase Kinases; Multimodal Imaging; Nitriles; Positron-Emission Tomography; Tomography, X-Ray Computed; Wilms Tumor	2013

Article

Year

Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth.

Molecular imaging and biology, 2013, Volume: 15, Issue:2

Topics: Animals; Butadienes; Female; Fluorodeoxyglucose F18; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase Kinases; Multimodal Imaging; Nitriles; Positron-Emission Tomography; Tomography, X-Ray Computed; Wilms Tumor

2013